Due to the federal government shutdown, the eCQI Resource Center has paused updates to site information including announcement requests. The digital Quality Measure (dQM) public comment period is also paused and will resume once normal government operations restart. The comment deadline will be extended to account for the length of the shutdown.
Top
Official websites use
.gov
A .gov website belongs to an official government organization in the United States.
Secure
.gov
websites use HTTPS
A
lock
(
)
or
https://
means you’ve safely connected to the
.gov
website. Share sensitive information only on official, secure websites.
["Medication, Active": "ACE Inhibitor or ARB or ARNI"]
Performance/Reporting Period
2021
Value Set Description from VSAC
Clinical Focus: This value set contains concepts that represent angiotensin-converting enzyme (ACE) inhibitor, angiotensin-receptor blocker (ARB), and angiotensin receptor-neprilysin inhibitor (ARNI) therapies.
Data Element Scope: This value set may use Quality Data Model (QDM) category related to Medication.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs concepts associated with component, form and strength); generic; prescribable; ACE inhibitor, ARB therapy, combination drugs such as ACEI plus diuretic, ARB plus neprilysin inhibitor (ARNI), ARB plus diuretic, ACEI plus calcium channel blocker, ARB plus calcium channel blocker, or ARB plus calcium channel blocker plus diuretic.
Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.
Data Element Scope: This value set may use Quality Data Model (QDM) category related to Medication.
Inclusion Criteria: Includes only relevant concepts associated with semantic clinical drugs concepts associated with component, form and strength); generic; prescribable; ACE inhibitor, ARB therapy, combination drugs such as ACEI plus diuretic, ARB plus neprilysin inhibitor (ARNI), ARB plus diuretic, ACEI plus calcium channel blocker, ARB plus calcium channel blocker, or ARB plus calcium channel blocker plus diuretic.
Exclusion Criteria: Excludes branded drugs; components or ingredients only; non-prescribable.
Constrained to codes in the Medication, Active: ACE Inhibitor or ARB or ARNI value set (2.16.840.1.113883.3.526.3.1139)
QDM Datatype and Definition
"Medication, Active"
Data elements that meet criteria using this datatype should document that the medication indicated by the QDM category and its corresponding value set is being taken by the patient. Keep in mind that when this datatype is used with timing relationships, the criterion is looking for a medication being taken for the time frame indicated by the timing relationships.
A QDM Known Issue has been identified related to this datatype. To see this QDM known Issue, please click here.
Timing:
- relevant dateTime references the time the medication is active on the medication record if it was given or taken at a single point in time.
- relevantPeriod references a start and stop time for an active medication on the medication record that is given or taken over a time interval:
- The relevantPeriod addresses:
- startTime - when the medication is first known to be used (generally the time of entry on the medication list).
- stopTime - when the medication is no longer active.
In the original QDM 5.5 publication, stopTime stated: when the medication is discontinued (generally, the time discontinuation is recorded on the medication list). See Appendix 6.3 for clarification regarding definition of "Medication, Active" relevantPeriod stopTime.
QDM Attributes
relevantPeriod
Relevant Period addresses the time between the start of an action to the end of an action. Each datatype using relevant period defines specific definitions for the start and stop time for the action listed.
Note: negation rationale indicates a one-time documentation of a reason an activity is not performed. Negation of QDM datatyperelated actions for a reason always use the author dateTime attribute to reference timing and must not use relevantPeriod
Last Updated: Jul 08, 2021